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Summary 
Possibilities to study the biology of human protozoan parasites and their interaction with the 
host remain severely limited, either because of non-existent or inappropriate animal models or 
because parasites cannot even be cultured in vitro due to strict human-host specificity or 
physiology. Here we discuss the prospects of using induced pluripotent stem cell (iPSC)-
derived culture systems including organoids as a strategy to address many of these experi-
mental bottlenecks. iPSCs already allow the generation of differentiated cell cultures for  
many human organs, and these cells and derivatives are amenable to reverse genetics in com-
bination with advanced tools for genetic manipulation. We present examples of blood, neu-
ron, liver, and intestine-dwelling protozoa, i.e. Plasmodium falciparum, Toxoplasma gondii 
and Giardia duodenalis, where iPSCs or organoids would allow addressing questions of cell 
and developmental biology, immunology, and pharmacology in unprecedented ways. Starting 
points and resources for iPSC experimentation are briefly discussed. 
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Introduction 
The ability to propagate pathogens in vitro 
in order to study their biology and interac-
tion with their host is a prerequisite for 
understanding infectious diseases, and this 
is as important today as it was for Robert 
Koch when he first identified and culti-
vated Bacillus anthracis as the etiological 
agent causing anthrax (Koch, 1876). The 
study of protozoan parasites is no excep-
tion to this. Although a substantial body of 
literature exists describing in vitro methods 
for their propagation (e.g. Taylor and 
Baker, 1987; Visvesvara and Garcia, 2002) 
a large number of problems and restric-
tions remain. 
Some parasites cannot be cultivated in vi-
tro at all, e.g. Cyclospora cayetanensis 
(Ortega and Sanchez, 2010); for others 
such as Cryptosporidium sp. (Arrowood, 
2002) or Giardia duodenalis (Benere et al., 
2010), existing in vitro or in vivo systems 
are unsatisfactory, and axenic culture sys-
tems that would allow one to dissect bio-
chemical dependencies for growth are not 
available for most medically important 
parasites, including all Apicomplexa. Host 
specificity is another important obstacle 
against the propagation of protozoan, in 
particular intracellular parasites, such as 
Plasmodium sp. or Eimeria sp., or for 
studying host species-restricted life cycle 
segments such as sexual reproduction of 
the apicomplexan parasites Toxoplasma 
gondii and Neospora caninum, which only 
occur in feline or canine hosts, respec-
tively. The recent progress in stem cell 
biology, i.e. the in vitro generation of 
pluripotent stem cells and organoids from 
those, holds great promise as a solution for 
a number of the aforementioned problems 
in the study of specific, mainly human 
host-parasite combinations. In this review 
we aim to highlight some of the opportuni-
ties and remaining challenges of these de-
velopments for the study of protozoan 
parasites by focusing on select examples. 
What are stem cells, and how can they 
be generated in vitro? 
In 1998 the propagation of pluripotent cells 
from human blastocysts, cultured on 
mouse embryonic fibroblasts in serum-
containing media, was reported (Thomson 
et al., 1998). Thus, a protocol became 
available for the derivation of human – in 
this case embryonic – stem cells, i.e. cells 
with the capacity for long-term self-
renewal and the potential to differentiate 
into the components and derivatives of all 
three embryonic germ layers. While this 
was a technical breakthrough, it immedi-
ately provoked a necessary ethical discus-
sion (Miller and Bloom, 1998) and subse-
quently led to legislation in different coun-
tries to regulate when and how the tech-
nique or working with human embryonic 
stem cells (hESCs) would be acceptable 
(e.g. in Germany see 
http://www.rki.de/DE/ Content/ Kommis-
sionen /ZES/zes_node.html). Eight years 
later Takahashi and Yamanaka published a 
protocol that allowed for the reprogram-
ming of differentiated murine fibroblasts 
by expression of just four transcription 
factors, Oct-4, Sox-2, Krüppel-like factor 4 
(Klf-4), and c-myc (Takahashi and 
Yamanaka, 2006). Thereby they were able 
to re-establish the intracellular signaling 
circuitry that induces pluripotent stem cells 
(iPSCs). Since then several solutions for 
delivering such reprogramming factors into 
mouse and human somatic cells have been 
developed even to the level of commercial 
products, and these include alternatives 
such as using small molecules and miR-
NAs (for review see Hanna et al., 2010; 
Robinton and Daley, 2012; see also Sup-
plementary Table 1 for selected iPSC-
related resources). The iPSC technology 
not only poses less severe ethical issues, it 
also offers a real possibility to study the 
basis of genetic diseases, because iPSC 
lines can be established from affected pa-
tients (Sadelain et al., 2011). Additionally, 
protocols to re-derive differentiated cells 
of different types from iPSC are rapidly 
being developed.  Needless to say, these 
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advances together with initiatives to estab-
lish iPSC banks (Rao et al., 2012) open 
opportunities to study host species- and 
host genotype-specific parasite interac-
tions. Moreover, the possibility to geneti-
cally engineer human iPSCs with a high 
efficiency (Hockemeyer et al., 2011) in 
order to introduce at a defined site a trans-
gene or disrupt the endogenous gene(s), 
thus creating functional mutants, will add 
even more impetus to this (see next sec-
tion). In the context of protozoan parasitic 
infections, unlimited access to cells of the 
hematopoietic lineages, to neuronal cells, 
to liver and gastrointestinal cell types, or to 
organoids mimicking the respective organs 
is the promise that iPSCs of relevant host 
species hold (see below and Table 1). 
Methods for efficient transdifferentiation 
of readily available cells such as fibro-
blasts to more difficult-to-get cells com-
plement the choices (Vierbuchen and 
Wernig, 2011). 
Generation of human hematopoietic 
cells with designed genetic makeup – a 
novel resource for studying Plasmodium-
erythrocyte interactions 
iPSCs are an attractive platform for the 
propagation of human Plasmodium species 
due to the strict host cell specificity of the 
latter for human erythrocytes or hepato-
cytes (Schuster, 2002). Recent advances in 
the field of large-scale in vitro production 
of functional red blood cells (RBCs) from 
iPSCs (for review see Dravid and Crooks, 
2011; Timmins and Nielsen, 2011) provide 
exciting opportunities for studying the re-
spective host-parasite interactions. 
Through evolution, the burden of human 
malaria has resulted in the selection of a 
number of gene mutations in the human 
population that affect RBC function. These 
mutations lower morbidity and mortality 
due to malaria in the affected human be-
ings (Bauduer, 2012; Gouagna et al., 2010) 
and have provided important clues to the 
intraerythrocytic biology of P. falciparum. 
It can be assumed that more host erythro-
cyte proteins are important in this context, 
as suggested by recent studies (Bei et al., 
2010; Crosnier et al., 2011). Based on pro-
tocols described previously (Giarratana et 
al., 2005), these investigators used CD34+ 
precursor stem cells purified from human 
bone marrow and knocked down gly-
cophorin A and basigin, respectively, by 
RNAi before differentiating these cells to 
RBC and infecting them with P. falcipa-
rum. However, the potential of designing 
specific gene deletions, site-directed spe-
cific mutations and modifications or cor-
rections with the aid of so-called zinc fin-
ger nucleases (ZFNs; Collin and Lako, 
2011) or transcription activator-like effec-
tor nucleases (TALENs; Mussolino and 
Cathomen, 2012) in iPSCs (Hockemeyer et 
al., 2009; Hockemeyer et al., 2011) allows 
one to refine and extend the design of such 
experiments (see Fig. 1). The subsequent 
differentiation of such mutated cells into 
erythrocytes would greatly expand the rep-
ertoire of mutant erythrocytes amenable to 
functional testing. Moreover, access to 
human CD34+ precursor stem cells or al-
ready known mutant erythrocytes from 
patients is limited, and iPSC-derived eryth-
rocytes from such individuals would facili-
tate research on such P. falciparum-
infected cells. 
A further application of this technology is 
to humanize mice with such cells (Arnold 
et al., 2011; Legrand et al., 2009) in order 
to study many aspects of host-parasite rela-
tion in vivo in an unprecedented way. The 
generation of mice with gene defects that 
prevent formation of T and B cells (scid or 
rag mutations) and natural killer cells 
(through IL-2 receptor γ chain deficiency) 
resulted in models that sustain meaningful 
numbers of human blood cells (Ito et al., 
2002; Traggiai et al., 2004), and these 
models are continuously being improved 
(Brehm et al., 2012; Strowig and Flavell, 
2012). The individual techniques have all 
been described (see Fig. 1 and Table 1), 
and it is only a matter of time until the first 
studies implementing it for P. falciparum 
are published. 
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Human neuronal cell lines and 
Toxoplasma gondii 
One reason that T. gondii has emerged as a 
prominent model organisms for protozoan 
parasites is due to its ease of cultivation 
and its very broad host species and host 
cell range, including mutant cell lines that 
have been important to the study of many 
aspects of host-parasite interaction 
(Pfefferkorn, 1990). It could be argued that 
stem cell-derived systems offer little extra 
when studying T. gondii host-parasite in-
terplay. However, the latent, chronic stage 
of T. gondii, the so-called bradyzoites, are 
found predominantly in brain, heart, and 
muscle tissue. These tissues are readily 
available, e.g. from experimentally in-
fected mice, but equivalent human cells are 
difficult to obtain. iPSC-derived neuronal, 
cardiac, or muscle cells could, however, 
deliver sufficient quantities of well-defined 
samples that would enable comparative 
analyses relevant to human disease. For 
example, the recently reported direct re-
programming (transdifferentiation) of hu-
man fibroblasts into neurons (Ambasudhan 
et al., 2011; Pang et al., 2011; Pfisterer et 
al., 2011) opens exciting possibilities to 
study this particular host cell -parasite in-
teraction in more detail. It would allow the 
evaluation of results obtained with infected 
rodent neurons that suggested an influence 
of T. gondii on neuronal dopamine me-
tabolism (Prandovszky et al., 2011). 
Human stem cell-derived liver cells for 
Plasmodium research on sporozoite in-
vasion and development of exoerythro-
cytic forms (EEF) 
The clinically silent malaria liver stage has 
become a major research area, because it 
represents one of the bottlenecks in the 
Plasmodium life cycle and is probably the 
most promising stage for vaccine devel-
opment (Mueller et al., 2005; Nussenzweig 
et al., 1967). To date, the liver stage can 
only be studied in depth in animal models 
of malaria (there is no option for the hu-
man-specific Plasmodium species) and 
hepatocyte cell lines. Adult, untransformed 
human liver cells are not routinely used 
due to the fact that they do not proliferate 
in vitro and are difficult to cryopreserve 
(Terry and Hughes, 2009). Still very little 
is known as to why mammalian Plasmo-
dium sporozoites specifically target hepa-
tocytes as their primary host cells for sub-
sequent EEF development (Hafalla et al., 
2011; Silvie et al., 2008). Recent advances 
in differentiating human ESCs or iPSCs 
into hepatocyte-like cells (Chen et al., 
2012; Schwartz et al., 2005; Song et al., 
2009; Touboul et al., 2010) or to transdif-
ferentiate human fibroblasts into cells with 
hepatocyte-like properties (Sekiya and 
Suzuki, 2011) may for the first time offer 
opportunities to study aspects of this host 
cell specificity of human-specific liver 
stages of P. falciparum or P. vivax in more 
depth. Additionally, we lack knowledge 
about the full repertoire of antigens that are 
presented during the arrested EEF devel-
opment. Genetically attenuated parasites 
showing this arrest can confer protection in 
murine models (Mueller et al., 2005). Stem 
cell-derived human hepatocytes could help 
identify or test presented (protective) anti-
gens from respective mutants of human 
Plasmodium species in order to develop 
subunit vaccines against sporozoites and 
liver stages, as this is of high priority in 
combating malaria (Kappe et al., 2010). 
Non-parenchymatic liver cells (NPLCs), 
i.e. stellate cells, liver sinusoidal endothe-
lial cells (LSECs) and Kupffer cells, are 
highly specific cells with unique properties 
that contribute significantly to the liver 
tissue and are vitally important for liver 
function during homeostasis and infection 
(Protzer et al. 2012). While little is known 
about the role of NPLCs during the hepatic 
phase of human malaria, mouse data re-
vealed that during the transmigration 
event, sporozoites are in intimate contact 
with LSECs and pass through Kupffer cells 
in order to enter the liver (Frevert et al., 
2008; Klotz and Frevert, 2008). Obviously, 
the development of a method to derive 
NPLCs from stem cells would enable stud-
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ies on the role of these cells (e.g. for anti-
gen presentation during the hepatic stage 
of Plasmodium) to be intensified, but such 
a protocol is currently not available. Stud-
ies of E. histolytica-LSEC interactions 
(Faust et al., 2011) in order to better under-
stand the process behind amoebiasis-
induced liver abscesses could also benefit 
from stem cell-derived NPLCs. 
 
Intestinal organoids as a new tool for 
enteric protozoa and for studying habi-
tat-parasite interactions 
Intestinal protozoan parasites are phylo-
genetically quite divergent but share the 
gut as a common habitat or entry point into 
the host. These organisms possess diverse 
biology for survival and replication in dif-
ferent niches; for example G. duodenalis 
or Entamoeba spp. dwell in the intestinal 
lumen, and Cryptosporidium spp. or T. 
gondii live within intestinal cells (Stark et 
al., 2009). Research on many of these or-
ganisms is hampered by a lack of appro-
priate in vitro culture systems. Stem cell-
derived systems can offer new avenues to 
investigate the organ-specific interactions 
of these parasites. 
In seminal papers published in 2009, two 
independent research groups reported 
different methods for the establishment of 
stem cell-based organoids from primary 
mouse intestinal tissue (Ootani et al., 2009; 
Sato et al., 2009). Ootani and colleagues 
established a more complex culture system 
from minced whole intestinal tissue em-
bedded in a three-dimensional collagen 
structure with support of stromal cells 
(Ootani et al., 2009). Sato et al. succeeded 
in establishing organoid cultures from iso-
lated crypts and from single Lgr5 marker-
positive cells using a matrigel matrix and 
serum-free medium supplemented with 
Wnt antagonist R-Spondin1, TGF-beta 
signaling inhibitor Noggin and epidermal 
growth factor (Sato et al., 2009; Sato et al., 
2011b). The latter system is particularly 
attractive, as no stromal cell support is 
necessary and it can be implemented rela-
tively easily in most laboratories. We es-
tablished such organoids following the 
protocol of Sato et al. from primary mouse 
crypts isolated from various mouse strains 
(Fig. 2). The observed crypt-villus struc-
tures consist of all epithelial, stem cell-
derived progenitor cells, i.e. enterocytes, 
paneth cells, goblet cells and enteroendo-
crine cells, but lack cells of mesenchymal 
or hematopoietic lineages (Sato et al., 
2009). Organoids simulate the in vivo 
situation much better than for instance the 
intestinal cell lines currently used for 
studying host-parasite interactions in vitro. 
Additionally, they are amenable to live cell 
imaging techniques akin to intravital 
microscopy (Chieppa et al., 2006). 
Moreover, since organoids can be 
generated from different tissues of the gut, 
including the small intestine and colon 
(Sato et al., 2009; Sato et al., 2011a, b; Yui 
et al., 2012), site-specific interaction with a 
particular pathogen can be studied. 
Recently, human intestinal organoids have 
been successfully established on the one 
hand from hESCs and hiPSCs (McCracken 
et al., 2011; Spence et al., 2011), and on 
the other hand starting from primary hu-
man tissue out of healthy and diseased pa-
tients (Sato et al., 2011a). Therefore in the 
future, we might be able to establish new 
in vitro culture systems for the sparsely 
studied human intestinal protozoan para-
sites that are still inadequately cultured or 
not culturable (see Table 1). 
Giardia duodenalis 
While in vitro studies on G. duodenalis are 
relatively easy to perform, it is much more 
difficult to investigate the events in the 
host gut that lead to disease and pathology, 
particularly in humans. Currently, re-
searchers resort to animal models or stud-
ies of parasites with immortalized intesti-
nal cell lines, both of which have their ob-
vious and distinct limitations. The impact 
of the various proposed disease mecha-
nisms on parasite pathogenicity (reviewed 
in Ankarklev et al., 2010; Cotton et al., 
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2011), such as induction of apoptosis and 
loss of intestinal barrier function, and the 
role of putative parasite virulence factors 
in these processes is currently unknown. 
Intestinal organoid cultures derived from 
iPSCs or from human intestinal tissue 
would greatly advance our means to study 
G. duodenalis pathogenicity and could 
help define virulence factors relevant for 
human infection. Currently, intestinal 
organoids lack cells of the immune system 
but offer the possibility to study the direct 
interaction of the parasites with well-
differentiated intestinal epithelial tissue as 
well as early events during infection. Fur-
thermore, it seems possible to elucidate 
host factors affecting G. duodenalis infec-
tion outcome by using organoids derived 
either from patients with particular disease 
manifestations (e.g. from volunteers with 
symptomatic vs. asymptomatic infections) 
or from genetically modified iPSCs. 
Another attractive application for intestinal 
organoids is to use them to improve the 
success rate of parasite adaptation to in 
vitro culture from clinical material. Al-
though cell-free culture systems with tro-
phozoites derived from biopsies or gener-
ated from cysts via in vitro excystation 
have been pioneered (Bingham and Meyer, 
1979; Meyer, 1970), it is still not possible 
to derive cultures from all distinct G. duo-
denalis genotypes. This resulted in a large 
research bias towards  easily culturable 
isolates (Smith et al., 1982). An organoid 
infection system enabling the cultivation of 
so far non-culturable isolates would repre-
sent a breakthrough and, for example, es-
tablish the basis for functional epidemiol-
ogy of giardiasis. 
Toxoplasma gondii 
T. gondii’s usual port of entry into its hosts 
is through the intestinal route via ingestion 
of tissue cysts or oocysts. While this initial 
infection process is documented to some 
degree in mice (Barragan and Hitziger, 
2008; Barragan and Sibley, 2002) intesti-
nal organoids could provide a relevant 
model for studying this aspect in the hu-
man system. 
An exciting prospect of the use of intesti-
nal organoids is the possibility to approach 
the in vitro reconstruction of the sexual 
reproductive cycle of T. gondii. The latter 
plays a central role in the creation of geno-
types of different virulence, but at a scale 
that has previously not been anticipated 
(Rao et al., 2012; Wendte et al., 2011). 
Sexual differentiation only takes place in 
cats and other felids. Thus, the challenge is 
to establish feline intestinal organoids and 
find in vitro conditions that would allow 
the sexual cycle to commence (and finish). 
It would provide an opportunity to analyze 
this poorly understood process under de-
fined conditions and follow the process in 
real time through live cell imaging. Fur-
thermore, such a culture system may offer 
an initial platform for vaccine or drug test-
ing aimed at blocking oocyst formation 
and thereby dissemination. 
iPSCs as screening and evaluation plat-
forms for new drugs 
Although most of the excitement over us-
ing iPSCs for drug screening purposes is 
currently in the field of monogenic human 
diseases (Ebert and Svendsen, 2010; 
Grskovic et al., 2011), screening programs 
intended to identify novel anti-protozoan 
parasite drugs would also benefit from the 
availability of differentiated cells usually 
not easily accessible, for example neurons. 
Stem cell-derived, differentiated cells are 
thought to allow more sensitive pre-
clinical toxicology testing (i.e. for car-
diotoxicity, hepatotoxicity, genotoxicity, 
and reproductive toxicology) of drug can-
didates than conventional cell systems do 
(Davila et al., 2004). Also, exploring the 
basis of differential drug pharmacology, 
kinetics, and metabolism in different indi-
viduals (frequently reflected as apparent 
“resistance” against drug X) using iPSCs 
derived from such patients for a given 
parasitic disease could greatly help in tai-
loring treatment regimens with approved, 
cheap, and safe drugs, thereby possibly 
extending the half-life of some anti-
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infectives in the clinics as in the case of 
malaria (Kerb et al., 2009; Paganotti et al., 
2011). 
Conclusions 
Research exploiting iPSCs and their de-
rived cells is still a very young field. Obvi-
ously, iPSC-derived cells and organ-like 
models have a number of caveats and dis-
advantages. Establishing protocols for 
one’s own special purposes is not trivial. 
The requirement for expensive growth and 
differentiation factors currently make this 
approach very costly. Organ-like models 
still do not reproduce the situation in vivo; 
e.g. organoids often lack particular cell 
types such as immune cells or other com-
ponents of the mimicked organ (e.g. the 
flora in gastrointestinal organoids), and 
this might be problematic. However, many 
step-by-step protocols and commercially 
available reagents (including established 
human iPSCs) already exist, and methods 
improve at a remarkable speed. Prices for 
reagents depend on demand and can drop 
quickly. For particular research questions, 
lack of complexity (e.g. additional cell 
types) may also be advantageous, offering 
a basic cellular model where complexity 
levels can be added as desired. Thus, we 
believe that the promises iPSC-based ap-
proaches offer to the study of protozoan 
parasites and host-specific interactions are 
realistic, and the opportunities should be 
seized. 
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Table 1: Potential applications of stem cell-derived primary tissues/cells for research on the 
host-pathogen interaction of protozoan parasites 
Differentiated 
cells/tissue * 
(Stem) Cell source and 
technical references * 
Protozoan 
pathogen  






(Dravid and Crooks, 2011; 
Timmins and Nielsen, 2011) 
P. falciparum and      
P. vivax (blood stage) 
Babesia spp. 




Neurons Fibroblasts (transdifferentiation)  
(Ambasudhan et al., 2011; Pang 
et al., 2011; Pfisterer et al., 
2011) 
T. gondii Dissecting neuronal host-
parasite interaction of the 
latent parasite stage 
(bradyzoites) 
 hESCs, hiPSCs 
(Lie et al., 2012) 
  
Liver 
Hepatocytes hiPSCs, hESCs 
(Cai et al., 2007; Chen et al., 
2012; Duan et al., 2007; 
Schwartz et al., 2005; Song et 
al., 2009; Touboul et al., 2010) 





and antigen presentation 
in primary human 
(mutant) hepatocytes 
 Fibroblasts (transdifferentiation)  
(Sekiya and Suzuki, 2011) 
Entamoeba spp. Revealing underlying 
pathogenicity factors of 
human liver/hepatocyte 
destruction  
Hollow fiber / 
organoids 
miPSCs and mESCs 
(Amimoto et al., 2011; 





hiPSCs, human intestinal crypts 
(McCracken et al., 2011; Sato et 
al., 2011a; Spence et al., 2011) 
G. duodenalis  
 
Improved in vitro culture 
of specific genotypes, 
studying virulence/ 
pathogenicity factors 
 Mouse Lrg5+ cells, mouse 
intestinal crypts 
(Ootani et al., 2009; Sato et al., 
2011a, b,  2009) 
Entamoeba spp. 
Balantidium spp. 
Studying pathogenicity of 
intestinal amoebiasis and 
balantidiosis 
  Cryptosporidium spp. 
Cyclospora spp. 
Improved in vitro culture, 
drug and disinfectant 
screening, studying 
biology of life cycle 
stages, viability assays  
  T. gondii Recapitulating host-
parasite interactions at the 
primary infection site 
 
* The different stem cell sources and differentiated cells can be combined with different 
protozoa, depending on the intended experiment. 
Klotz et al. Parasite culturing and stem cells  8 
Legends to illustrations 
Figure 1 
Driven by specific mixes of growth and differentiation factors, a variety of defined, differentiated 
cell types and even organoids can be derived from iPSCs (for generic iPSC protocols see 
Rajarajan et al., 2012). Direct re-programming, i.e. transdifferentiation of fibroblasts etc., to neu-
rons by respective growth and differentiation factors is also possible. Engineered proteins con-
taining zinc fingers or transcription activator-like effector domains fused to nucleases, called 
ZFN and TALEN, respectively, are used to create double-strand DNA breaks at predetermined 
sites in the genome (for technical resources see Sanjana et al., 2012). The breaks in turn are re-
paired by end joining and, in the presence of DNA constructs homologous to the chosen region, 
by homologous recombination-mediated repair. Thereby site-specific mutations/insertions can be 
introduced at the level of starting cells (e.g. fibroblasts) or iPSCs. Infection of iPSCs, of iPSC-
derived cell types of organoids, or even of mice humanized by the engraftment of hematopoietic 
precursor cells etc., with the parasite of choice offer different avenues for pathogen propagation 
and host interaction studies. 
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Figure 2 
 
Intestinal organoid cultures to study host-parasite interaction. A, B: Long-term cultures of crypt-
derived intestinal organoids. Note the enclosed crypt-villous-like structures with luminal shed-
ding of jaded enterocytes. C1-C4: Confocal imaging of proliferating cells of organoid cultures 
visualized by 5-ethynyl-2'-deoxyuridine (Edu)-incorporation. C1, Dapi (blue,); C2, Edu (red); 
C3, Nomarski interference; C4, merge of C2 and C3. Scale bar = 20 µm. D1: Immunofluores-
cence image of an intestinal organoid infected with tachyzoites of the RH strain of T. gondii 48 h 
post infection. Dapi (blue); tachyzoite surface was stained with anti-SAG1 mab DG52 (green). 
The fluorescence image was merged with a Nomarski interference image. D2: Enlargement of the 
fluorescent image from D1 (white square). Note the rosette-like structures of intracellular para-
sites in the epithelial layer, typical of RH strain tachyzoite replication. 
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Supplementary Table 1: Selection of intenet addresses of iPSC and related resources 
Mouse stem cell resources URL 
RIKEN http://www2.brc.riken.jp/lab/cell/s5_list.cgi?key=e  
Mutant Mouse Regional Resource Centers 
(MMRRC) Baygenomics 
http://www.mmrrc.org/catalog/overview_BG.php     
EMMA – The European Mouse Mutant 
Archive 
http://www.emmanet.org/  
Mount Sinai School of Medicine Soriano 
Lab 
http://research.mssm.edu/soriano/lab/gene_trap.html  
Sanger Gene Trap Consortium  http://www.sanger.ac.uk/resources/mouse/sigtr/  
International Genetrap Consortium http://www.genetrap.org/  




Depositories of Human stem cells  & primary cells  




WiCEll Research Institute iPS Distribution http://www.wicell.org/index.php?option=com_content&task=category&
id=348&Itemid=262&sectionid=19  
International Stem Cell Repository http://www.umassmed.edu/iscr/index.aspx  






HSCI iPS Cell Core Facility http://www.hsci.harvard.edu/ipscore/node/3 
European Human Embryonic Stem Cell 
Registry 
http://www.hescreg.eu/ 
HPA Culture Collections http://www.hpacultures.org.uk/products/celllines/primarycells/index.jsp 
Health Science Research Resources Bank 
(Japan) 
http://www.jhsf.or.jp/bank/Category-Index.html 
System Biosciences (commercial) http://www.systembio.com/stem-cell-research/ips-cell-lines 





Plasmids for iPSC generation and modification at Addgene 
Plasmids for Stem Cell Research  http://www.addgene.org/stemcell/ 
Zinc Finger Consortium Reagents http://www.addgene.org/zfc/ 
TALEN Kits http://www.addgene.org/TALEN/ 
 
